Laropharm S.R.L.
Laropharm S.R.L., a prominent player in the pharmaceutical industry, is headquartered in Romania (RO) and operates extensively across Eastern Europe. Founded in 1998, the company has established itself as a leader in the development and distribution of high-quality pharmaceutical products, particularly in the fields of oncology, cardiology, and neurology. With a commitment to innovation, Laropharm S.R.L. offers a diverse portfolio of prescription medications and over-the-counter solutions that stand out for their efficacy and safety. The company has achieved significant milestones, including numerous certifications and partnerships that enhance its market position. Recognised for its dedication to research and development, Laropharm S.R.L. continues to contribute to the advancement of healthcare, making a meaningful impact on patients' lives across the region.
DitchCarbon Score
How does Laropharm S.R.L.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Laropharm S.R.L.'s score of 18 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Laropharm S.R.L.'s reported carbon emissions
In 2023, Laropharm S.R.L. reported total carbon emissions of approximately 13,275,740 kg CO2e. This figure includes 9,493,390 kg CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources, and 5,370,100 kg CO2e from Scope 2 emissions, related to indirect emissions from the generation of purchased electricity. Comparatively, in 2022, the company recorded total emissions of about 9,937,240 kg CO2e, with Scope 1 emissions at 9,937,240 kg CO2e and Scope 2 emissions at 5,259,210 kg CO2e. The 2023 emissions reflect a significant increase from the previous year, indicating a need for enhanced climate strategies. Despite the increase in emissions, Laropharm S.R.L. has not publicly disclosed specific reduction targets or initiatives aimed at mitigating their carbon footprint. The absence of defined climate pledges or science-based targets suggests that the company may be in the early stages of developing a comprehensive climate action plan. Overall, while Laropharm S.R.L. has made strides in tracking its emissions, further commitment to reduction strategies will be essential for aligning with industry standards and addressing climate change effectively.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2019 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 10,920,800 | 0,000,000 | 0,000,000 |
| Scope 2 | 4,996,690 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Laropharm S.R.L. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
